Newsletter Subject

Take immediate action... before it's too late

From

alsearsmd.com

Email Address

alsearsmd@send.alsearsmd.com

Sent On

Mon, Jan 23, 2023 07:04 PM

Email Preheader Text

The mainstream media is at it again... to view this message in your browser | to stop receiving our

The mainstream media is at it again... [Click here](1770d7/ct0_0/1/ms?sid=TV2%3AeegXLcrhI) to view this message in your browser | [Click here](1770d7/l-002e/zout?sid=TV2%3AeegXLcrhI) to stop receiving our messages [] [] Al Sears, MD 11905 Southern Blvd. Royal Palm Beach, FL 33411 [] January 23, 2023 [] Reader, The mainstream media is at it again...spreading more dangerous misinformation about Covid and pushing the idea that the only way you can protect yourself is with one of Big Pharma’s dangerous drugs. This time, the press is promoting a monoclonal antibody called tocilizumab. It’s the latest drug fast-tracked by the FDA for use in Covid patients. Sold under the name Actemra, tocilizumab is a powerful immunosuppressive drug typically prescribed to patients with severe rheumatoid arthritis. But like many FDA-approved medications, this drug comes with a “black box” warning. That’s the agency’s most extreme indication that a drug comes with “serious or life-threatening risks” – in this case - severe, and in some cases, fatal, infections. In the case of Actemra, we’re talking about more than 40,000 serious adverse events and more than 2,300 deaths.1 This latest “Covid drug push” comes on the tail of two earlier drug approvals... One of the drugs from Merck, called Lagevrio, is marketed as an at-home treatment for anyone who develops mild to moderate Covid symptoms. Big Pharma Drug Causes DNA Mutations? But there are terrifying consequences to using this drug... The key ingredient in Lagevrio is a mutagenic antiviral called molnupiravir. It’s designed to introduce mutations into the Covid virus’ genetic code. The theory is that these mutations will stop the virus from multiplying. Like Actemra, Molnupiravir also isn’t new. It’s been around since 2003, when the first prototype was developed by scientists at Emory University. But the lead chemist on the project abandoned his research after the drug’s dangerous side effects and safety issues came to light. You see, while the drug is supposed to target viral RNA (as if that’s not scary enough), it’s highly likely that it will cause mutations in human DNA. These mutations include cancerous tumors and horrific birth defects. But even more disturbing is that no one knows what the future effects of taking this untested pill will be. The clinical trial done by the pharmaceutical company was nowhere near long enough to determine what could happen years down the road. Big Pharma’s Pattern Of Putting Patients Last It brings to mind another drug produced by Merck. Do you remember Vioxx, the painkiller that was deemed safe in early studies and approved by the FDA – despite agency insiders knowing full well that it could conceivably hurt the heart? It was only years later that a longer-term study found a definite link between Vioxx and heart disease deaths which killed up to 56,000 people and left hundreds of thousands injured. But that doesn’t seem to concern Merck. Why would it when this Covid drug is predicted to be a $10 billion cash cow? In fact, the U.S. government has already purchased more than 3 million doses of Lagevrio. Today, I’m joining the growing number of prominent voices who are sounding the alarm over these terrifying and unnecessary drugs. And I’m going to tell you the same thing I tell my patients and my family... You don’t need this dangerous Big Pharma drug. With more than 30 years of clinical experience as both a doctor and a researcher, I have discovered that you have all the immune strength you need already inside of you. And when you support and nourish it, you don’t ever need to rely on Big Pharma’s drugs. I’ve put in thousands of hours of research over the years. And I’ve talked to some of the best and brightest minds in the field of anti-aging and regenerative medicine. I’ve seen the results in my own patients as well as my family and myself. You have options – natural and safe options that work. Join me for my Shield Immunity Protocol event this FILL IN DATE HERE at noon to hear more about them. You cannot afford to miss this. Please note there is no fee to join me for this event, but we are using an online service to host it, and they require pre-registration. Please sign up for this important event here. You cannot afford to miss this. [Please sign up for this important event here](1770d7/ct1_0/1/lu?sid=TV2%3AeegXLcrhI). To Your Good Health, Al Sears, MD, CNS --------------------------------------------------------------- References: 1. Plummer J, et al. “Selenium supplementation inhibits IGF-1 signaling and confers methionine restriction-like healthspan benefits to mice.” Elife. 2021 Mar 30;10:e62483. alsearsmd@send.alsearsmd.com [Preferences | Unsubscribe](1770d7/l-002e/zout?sid=TV2%3AeegXLcrhI) 11905 Southern Blvd., Royal Palm Beach, Florida 33411, United States

Marketing emails from alsearsmd.com

View More
Sent On

08/12/2024

Sent On

05/12/2024

Sent On

04/12/2024

Sent On

30/11/2024

Sent On

29/11/2024

Sent On

28/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.